annual EBITDA:
$220.11M-$20.19M(-8.40%)Summary
- As of today (July 27, 2025), AMPH annual EBITDA is $220.11 million, with the most recent change of -$20.19 million (-8.40%) on December 31, 2024.
- During the last 3 years, AMPH annual EBITDA has risen by +$108.55 million (+97.30%).
- AMPH annual EBITDA is now -8.40% below its all-time high of $240.29 million, reached on December 31, 2023.
Performance
AMPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$52.35M-$12.70M(-19.52%)Summary
- As of today (July 27, 2025), AMPH quarterly EBITDA is $52.35 million, with the most recent change of -$12.70 million (-19.52%) on March 31, 2025.
- Over the past year, AMPH quarterly EBITDA has dropped by -$18.09 million (-25.68%).
- AMPH quarterly EBITDA is now -42.41% below its all-time high of $90.91 million, reached on September 30, 2023.
Performance
AMPH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$259.22M-$18.09M(-6.53%)Summary
- As of today (July 27, 2025), AMPH TTM EBITDA is $259.22 million, with the most recent change of -$18.09 million (-6.53%) on March 31, 2025.
- Over the past year, AMPH TTM EBITDA has dropped by -$10.16 million (-3.77%).
- AMPH TTM EBITDA is now -13.29% below its all-time high of $298.95 million, reached on June 30, 2024.
Performance
AMPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMPH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.4% | -25.7% | -3.8% |
| 3 y3 years | +97.3% | +44.7% | +91.0% |
| 5 y5 years | +170.2% | +347.4% | +767.6% |
AMPH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.4% | +97.3% | -42.4% | +72.3% | -13.3% | +98.3% |
| 5 y | 5-year | -8.4% | +629.0% | -42.4% | >+9999.0% | -13.3% | +767.6% |
| alltime | all time | -8.4% | +1192.2% | -42.4% | +886.1% | -13.3% | +1755.8% |
AMPH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $52.35M(-19.5%) | $259.22M(-6.5%) |
| Dec 2024 | $220.11M(-8.4%) | $65.05M(-5.5%) | $277.31M(+0.2%) |
| Sep 2024 | - | $68.81M(-5.7%) | $276.85M(-7.4%) |
| Jun 2024 | - | $73.00M(+3.6%) | $298.95M(+11.0%) |
| Mar 2024 | - | $70.45M(+9.1%) | $269.38M(+12.1%) |
| Dec 2023 | $240.29M(+64.4%) | $64.59M(-29.0%) | $240.29M(+6.9%) |
| Sep 2023 | - | $90.91M(+109.3%) | $224.82M(+36.8%) |
| Jun 2023 | - | $43.43M(+5.0%) | $164.40M(+8.6%) |
| Mar 2023 | - | $41.36M(-15.8%) | $151.34M(+3.5%) |
| Dec 2022 | $146.16M(+31.0%) | $49.11M(+61.1%) | $146.16M(+11.8%) |
| Sep 2022 | - | $30.49M(+0.4%) | $130.71M(-9.8%) |
| Jun 2022 | - | $30.38M(-16.0%) | $144.91M(+6.8%) |
| Mar 2022 | - | $36.18M(+7.5%) | $135.70M(+21.6%) |
| Dec 2021 | $111.56M(+269.5%) | $33.66M(-24.7%) | $111.56M(+43.0%) |
| Sep 2021 | - | $44.68M(+111.1%) | $78.01M(+65.1%) |
| Jun 2021 | - | $21.17M(+75.8%) | $47.25M(+54.8%) |
| Mar 2021 | - | $12.04M(>+9900.0%) | $30.53M(+1.1%) |
| Dec 2020 | $30.19M(-62.9%) | $116.00K(-99.2%) | $30.19M(-18.3%) |
| Sep 2020 | - | $13.92M(+212.9%) | $36.93M(+23.6%) |
| Jun 2020 | - | $4.45M(-62.0%) | $29.88M(-67.4%) |
| Mar 2020 | - | $11.70M(+70.6%) | $91.64M(+12.5%) |
| Dec 2019 | $81.47M(+1092.3%) | $6.86M(-0.2%) | $81.47M(+2.4%) |
| Sep 2019 | - | $6.87M(-89.6%) | $79.58M(-0.0%) |
| Jun 2019 | - | $66.21M(+4230.4%) | $79.58M(+491.9%) |
| Mar 2019 | - | $1.53M(-69.2%) | $13.44M(+96.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $6.83M(-61.8%) | $4.97M(-27.7%) | $6.83M(+40.7%) |
| Sep 2018 | - | $6.87M(+9060.0%) | $4.86M(+1627.8%) |
| Jun 2018 | - | $75.00K(-101.5%) | $281.00K(-96.2%) |
| Mar 2018 | - | -$5.08M(-269.9%) | $7.46M(-58.7%) |
| Dec 2017 | $17.89M(-41.0%) | $2.99M(+30.3%) | $18.05M(+28.1%) |
| Sep 2017 | - | $2.30M(-68.3%) | $14.10M(-35.3%) |
| Jun 2017 | - | $7.25M(+31.4%) | $21.80M(-22.8%) |
| Mar 2017 | - | $5.52M(-670.4%) | $28.22M(-7.0%) |
| Dec 2016 | $30.33M(+682.8%) | -$967.00K(-109.7%) | $30.33M(-32.8%) |
| Sep 2016 | - | $10.00M(-26.9%) | $45.12M(+31.0%) |
| Jun 2016 | - | $13.67M(+79.3%) | $34.44M(+144.1%) |
| Mar 2016 | - | $7.63M(-44.8%) | $14.11M(+264.1%) |
| Dec 2015 | $3.88M(-225.4%) | $13.82M(-2129.4%) | $3.88M(-130.9%) |
| Sep 2015 | - | -$681.00K(-89.8%) | -$12.54M(-19.9%) |
| Jun 2015 | - | -$6.66M(+155.8%) | -$15.65M(+129.6%) |
| Mar 2015 | - | -$2.60M(+0.5%) | -$6.82M(+120.6%) |
| Dec 2014 | -$3.09M(-109.9%) | -$2.59M(-31.8%) | -$3.09M(-151.8%) |
| Sep 2014 | - | -$3.80M(-274.6%) | $5.96M(-56.0%) |
| Jun 2014 | - | $2.18M(+93.7%) | $13.56M(-49.5%) |
| Mar 2014 | - | $1.12M(-82.6%) | $26.85M(-14.1%) |
| Dec 2013 | $31.26M(-18.1%) | $6.46M(+70.1%) | $31.26M(+26.1%) |
| Sep 2013 | - | $3.80M(-75.4%) | $24.80M(+18.1%) |
| Jun 2013 | - | $15.46M(+179.4%) | $21.00M(+279.4%) |
| Mar 2013 | - | $5.54M | $5.54M |
| Dec 2012 | $38.16M(-289.3%) | - | - |
| Dec 2011 | -$20.15M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of AMPH is $220.11M
What is the all time high annual EBITDA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual EBITDA is $240.29M
What is Amphastar Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, AMPH annual EBITDA has changed by -$20.19M (-8.40%)
What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of AMPH is $52.35M
What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly EBITDA is $90.91M
What is Amphastar Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, AMPH quarterly EBITDA has changed by -$18.09M (-25.68%)
What is Amphastar Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of AMPH is $259.22M
What is the all time high TTM EBITDA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM EBITDA is $298.95M
What is Amphastar Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, AMPH TTM EBITDA has changed by -$10.16M (-3.77%)